Simon Castleden
Impact in
- Genetics top 5%
- Virus-based gene therapy research
- Biotechnology top 5%
- Cancer Research and Treatments
Papers in
- Genetics 5
- Virus-based gene therapy research 5
-
- RNA Interference and Gene Delivery 3
- Viral Infectious Diseases and Gene Expression in Insects 1
- CRISPR and Genetic Engineering 1
- Co-authors
- Richard G. Vile (5 shared papers)Heung Chong (4 shared papers)Ian R. Hart (2 shared papers)J. Arly Nelson (1 shared paper)Richard S. Camplejohn (2 shared papers)John F. Marshall (1 shared paper)Carol Upton (2 shared papers)Rosa María Díaz (1 shared paper)
- Journals
- International Journal of Cancer (2 papers)Human Gene Therapy (1 paper)Biochemical Society Transactions (1 paper)Molecular Biotechnology (1 paper)PubMed (1 paper)
- Partner nations
- United KingdomCanadaUnited States
In The Last Decade
Simon Castleden
6 papers receiving 538 citations
Peers
Comparison fields: 5 of 45
- Genetics 409
- Biotechnology 110
- Immunology 148
- Oncology 171
- Molecular Biology 285
Countries citing papers authored by Simon Castleden
This map shows the geographic impact of Simon Castleden's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Simon Castleden with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Simon Castleden more than expected).
Fields of papers citing papers by Simon Castleden
This network shows the impact of papers produced by Simon Castleden. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Simon Castleden. The network helps show where Simon Castleden may publish in the future.
Co-authors
The 14 scholars most cited alongside Simon Castleden, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Systemic gene therapy of murine melanoma using tissue specific expression of the HSVtk gene involves an immune component. | 1994 | 281 |
| 2 | 1997 | 172 | |
| 3 | 1996 | 49 | |
| 4 | 1997 | 37 | |
| 5 | 1997 | 21 | |
| 6 | 1997 | 3 |
About Simon Castleden
Simon Castleden is a scholar working on Genetics, Molecular Biology, Immunology, Epidemiology and Oncology, having authored 6 papers that have together received 563 indexed citations. Recurring topics across this work include Virus-based gene therapy research (5 papers), Immunotherapy and Immune Responses (4 papers), RNA Interference and Gene Delivery (3 papers), Herpesvirus Infections and Treatments (2 papers), Viral Infectious Diseases and Gene Expression in Insects (1 paper), Cancer Immunotherapy and Biomarkers (1 paper), Immune Response and Inflammation (1 paper) and CRISPR and Genetic Engineering (1 paper). The work is most often cited by research in Genetics (409 citations), Biotechnology (110 citations), Immunology (148 citations), Oncology (171 citations) and Molecular Biology (285 citations). Simon Castleden has collaborated with scholars based in United Kingdom, Canada and United States. Frequent co-authors include Richard G. Vile, Heung Chong, Ian R. Hart, J. Arly Nelson, Richard S. Camplejohn, John F. Marshall, Carol Upton, Rosa María Díaz, R G Vile and H. Chong. Their work appears in journals such as International Journal of Cancer, Human Gene Therapy, Biochemical Society Transactions, Molecular Biotechnology and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.